Business

Vireo Growth Inc. Enters into Definitive Agreements to Acquire Outstanding Senior Secured Convertible Notes of Schwazze

– Transaction reflects continuation of Vireo’s M&A strategy and is expected to close later this month –MINNEAPOLIS, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF) today announced that it has entered into definitive agreements to acquire approximately 86% of the outstanding senior secured convertible notes (the “Notes”) of public U.S. multi-state cannabis operator, Medicine Man Technologies Inc. (dba “Schwazze”) from third-party noteholder

articleVireo Growth IncOctober 2, 20255/company/vireo-growth-inc/news/vireo-growth-inc-enters-into-definitive-agreements-to-acquire-outstanding-senior-secured-convertible-notes-of-schwazze
Vireo Growth Inc. Enters into Definitive Agreements to Acquire Outstanding Senior Secured Convertible Notes of Schwazze

About this update from Vireo Growth Inc

[{"type":"image","alt":"Vireo Growth Inc.","displaySize":"","headline":null,"caption":"Vireo Growth Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":130,"url":"https://media.zenfs.com/en/globenewswire.com/e9ac63f691ebe4f43846df7f4e7f62a4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/u5L1XWvWlDJUxUGOnpDHuA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE4MjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e9ac63f691ebe4f43846df7f4e7f62a4","width":300,"height":130}},"lazy":false},{"type":"text","content":"– Transaction reflects continuation of Vireo’s M&A strategy and is expected to close later this month –","length":107,"tagName":"p"},{"type":"text","content":"MINNEAPOLIS, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF) today announced that it has entered into definitive agreements to acquire approximately 86% of the outstanding senior secured convertible notes (the “Notes”) of public U.S. multi-state cannabis operator, Medicine Man Technologies Inc. (dba “Schwazze”) from third-party noteholders. The Notes will be acquired at a price substantially below par value, for total consideration of approximately $62 million payable in subordinate voting shares of the Company at closing, at a deemed price per share of $0.54.","length":643,"tagName":"p"},{"type":"text","content":"The transaction is expected to close later this month. Completion of the transaction is subject to customary conditions, including receipt of necessary approvals.","length":162,"tagName":"p"},{"type":"text","content":"About Vireo Growth Inc. ","length":23,"tagName":"p"},{"type":"text","content":"Vireo was founded in 2014 as a pioneering medical cannabis company. Vireo is building a disciplined, strategically aligned, and execution-focused platform in the industry. This strategy drives our intense local market focus while leveraging the strength of a national portfolio. We are committed to hiring industry leaders and deploying capital and talent where we believe it will drive the most value. Vireo operates with a long-term mindset, a bias for action, and an unapologetic commitment to its customers, employees, shareholders, industry collaborators, and the communities it serves. For more information about Vireo, visit www.vireogrowth.com.","length":652,"tagName":"p"},{"t...

More updates from Vireo Growth Inc

Vireothe Companycustomary conditionsCompanyVireo Growth Inc.Canadian securitiesMedicine Man Technologies Inc.forward-looking statementsU.S.statements